187 related articles for article (PubMed ID: 26189129)
1. Molecular profiling of intrahepatic and extrahepatic cholangiocarcinoma using next generation sequencing.
Putra J; de Abreu FB; Peterson JD; Pipas JM; Mody K; Amos CI; Tsongalis GJ; Suriawinata AA
Exp Mol Pathol; 2015 Oct; 99(2):240-4. PubMed ID: 26189129
[TBL] [Abstract][Full Text] [Related]
2. Clinically significant genomic alterations in the Chinese and Western patients with intrahepatic cholangiocarcinoma.
Xu S; Guo Y; Zeng Y; Song Z; Zhu X; Fan N; Zhang Z; Ren G; Zang Y; Rao W
BMC Cancer; 2021 Feb; 21(1):152. PubMed ID: 33579226
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral heterogeneity of intrahepatic cholangiocarcinoma.
Walter D; Döring C; Feldhahn M; Battke F; Hartmann S; Winkelmann R; Schneider M; Bankov K; Schnitzbauer A; Zeuzem S; Hansmann ML; Peveling-Oberhag J
Oncotarget; 2017 Feb; 8(9):14957-14968. PubMed ID: 28146430
[TBL] [Abstract][Full Text] [Related]
4. Molecular profiling in cholangiocarcinoma: A practical guide to next-generation sequencing.
Stenzinger A; Vogel A; Lehmann U; Lamarca A; Hofman P; Terracciano L; Normanno N
Cancer Treat Rev; 2024 Jan; 122():102649. PubMed ID: 37984132
[TBL] [Abstract][Full Text] [Related]
5. Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes.
Sia D; Hoshida Y; Villanueva A; Roayaie S; Ferrer J; Tabak B; Peix J; Sole M; Tovar V; Alsinet C; Cornella H; Klotzle B; Fan JB; Cotsoglou C; Thung SN; Fuster J; Waxman S; Garcia-Valdecasas JC; Bruix J; Schwartz ME; Beroukhim R; Mazzaferro V; Llovet JM
Gastroenterology; 2013 Apr; 144(4):829-40. PubMed ID: 23295441
[TBL] [Abstract][Full Text] [Related]
6. Mutational spectrum and precision oncology for biliary tract carcinoma.
Lin J; Cao Y; Yang X; Li G; Shi Y; Wang D; Long J; Song Y; Mao J; Xie F; Bai Y; Zhang L; Yang X; Wan X; Wang A; Guan M; Zhao L; Hu K; Pan J; Huo L; Lu X; Mao Y; Sang X; Zhang H; Wang K; Wang X; Zhao H
Theranostics; 2021; 11(10):4585-4598. PubMed ID: 33754015
[No Abstract] [Full Text] [Related]
7. Autophagy activity in cholangiocarcinoma is associated with anatomical localization of the tumor.
Lendvai G; Szekerczés T; Illyés I; Csengeri M; Schlachter K; Szabó E; Lotz G; Kiss A; Borka K; Schaff Z
PLoS One; 2021; 16(6):e0253065. PubMed ID: 34129628
[TBL] [Abstract][Full Text] [Related]
8. Identification of a Novel EHBP1-MET Fusion in an Intrahepatic Cholangiocarcinoma Responding to Crizotinib.
Yu Y; Liu Q; Li W; Qu Y; Zhang Y; Liu T
Oncologist; 2020 Dec; 25(12):1005-1008. PubMed ID: 32897609
[TBL] [Abstract][Full Text] [Related]
9. Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma.
Montal R; Sia D; Montironi C; Leow WQ; Esteban-Fabró R; Pinyol R; Torres-Martin M; Bassaganyas L; Moeini A; Peix J; Cabellos L; Maeda M; Villacorta-Martin C; Tabrizian P; Rodriguez-Carunchio L; Castellano G; Sempoux C; Minguez B; Pawlik TM; Labgaa I; Roberts LR; Sole M; Fiel MI; Thung S; Fuster J; Roayaie S; Villanueva A; Schwartz M; Llovet JM
J Hepatol; 2020 Aug; 73(2):315-327. PubMed ID: 32173382
[TBL] [Abstract][Full Text] [Related]
10. Molecular Profile of Intrahepatic Cholangiocarcinoma.
Andraus W; Tustumi F; de Meira Junior JD; Pinheiro RSN; Waisberg DR; Lopes LD; Arantes RM; Rocha Santos V; de Martino RB; Carneiro D'Albuquerque LA
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203635
[TBL] [Abstract][Full Text] [Related]
11. VIRMA facilitates intrahepatic cholangiocarcinoma progression through epigenetic augmentation of TMED2 and PARD3B mRNA stabilization.
Xu H; Lin X; Li Z; He X; Li Y; Qiu L; Lu L; Liu B; Zhan M; He K
J Gastroenterol; 2023 Sep; 58(9):925-944. PubMed ID: 37391589
[TBL] [Abstract][Full Text] [Related]
12. Exploring the Clinical Use of Molecular Profiling of Intrahepatic Cholangiocarcinoma in a Comprehensive Multidisciplinary Clinic.
Purchla J; Ghabi EM; Burns WR; Lafaro KJ; Burkhart RA; Cameron JL; Yarchoan M; Shubert CR; Baretti M; He J
J Am Coll Surg; 2024 Apr; 238(4):532-540. PubMed ID: 38189646
[TBL] [Abstract][Full Text] [Related]
13. Practical considerations for pathological diagnosis and molecular profiling of cholangiocarcinoma: an expert review for best practices.
Evans M; Kendall T
Expert Rev Mol Diagn; 2024 May; 24(5):393-408. PubMed ID: 38752560
[TBL] [Abstract][Full Text] [Related]
14. Molecular profiling and prognostic analysis in Chinese cholangiocarcinoma: an observational, retrospective single-center study.
Zhang C; You X; Zhang Q; Wang D
Invest New Drugs; 2024 Feb; 42(1):24-34. PubMed ID: 37975978
[TBL] [Abstract][Full Text] [Related]
15. In Vivo Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma.
Younger NT; Wilson ML; Martinez Lyons A; Jarman EJ; Meynert AM; Grimes GR; Gournopanos K; Waddell SH; Tennant PA; Wilson DH; Guest RV; Wigmore SJ; Acosta JC; Kendall TJ; Taylor MS; Sproul D; Mill P; Boulter L
Cancer Res; 2022 Apr; 82(8):1548-1559. PubMed ID: 35074757
[TBL] [Abstract][Full Text] [Related]
16. The immunogenomic landscape of resected intrahepatic cholangiocarcinoma.
Carapeto F; Bozorgui B; Shroff RT; Chagani S; Solis Soto L; Foo WC; Wistuba I; Meric-Bernstam F; Shalaby A; Javle M; Korkut A; Kwong LN
Hepatology; 2022 Feb; 75(2):297-308. PubMed ID: 34510503
[TBL] [Abstract][Full Text] [Related]
17. The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma.
Pappas L; Baiev I; Reyes S; Bocobo AG; Jain A; Spencer K; Le TM; Rahma OE; Maurer J; Stanton J; Zhang K; De Armas AD; Deleon TT; Roth M; Peters MLB; Zhu AX; Boyhen K; VanCott C; Patel T; Roberts LR; Lindsey S; Horick N; Lennerz JK; Iafrate AJ; Goff LW; Mody K; Borad MJ; Shroff RT; Javle MM; Kelley RK; Goyal L
JCO Precis Oncol; 2023 Aug; 7():e2200594. PubMed ID: 37561981
[TBL] [Abstract][Full Text] [Related]
18. Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012.
Florio AA; Ferlay J; Znaor A; Ruggieri D; Alvarez CS; Laversanne M; Bray F; McGlynn KA; Petrick JL
Cancer; 2020 Jun; 126(11):2666-2678. PubMed ID: 32129902
[TBL] [Abstract][Full Text] [Related]
19. Current challenges to underpinning the genetic basis for cholangiocarcinoma.
Cigliano A; Chen X; Calvisi DF
Expert Rev Gastroenterol Hepatol; 2021 May; 15(5):511-526. PubMed ID: 33888034
[TBL] [Abstract][Full Text] [Related]
20. Identification of Circulating Genomic and Metabolic Biomarkers in Intrahepatic Cholangiocarcinoma.
Winter H; Kaisaki PJ; Harvey J; Giacopuzzi E; Ferla MP; Pentony MM; Knight SJL; Sharma RA; Taylor JC; McCullagh JSO
Cancers (Basel); 2019 Nov; 11(12):. PubMed ID: 31795195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
